首页> 外文期刊>Scientific reports. >A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression
【24h】

A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression

机译:基于系统机器学习的非酒精性脂肪肝疾病风险和进展诊断方法

获取原文
           

摘要

Prevention and diagnosis of NAFLD is an ongoing area of interest in the healthcare community. Screening is complicated by the fact that the accuracy of noninvasive testing lacks specificity and sensitivity to make and stage the diagnosis. Currently no non-invasive ATP III criteria based prediction method is available to diagnose NAFLD risk. Firstly, the objective of this research is to develop machine learning based method in order to identify individuals at an increased risk of developing NAFLD using risk factors of ATP III clinical criteria updated in 2005 for Metabolic Syndrome (MetS). Secondly, to validate the relative ability of quantitative score defined by Italian Association for the Study of the Liver (IASF) and guideline explicitly defined for the Canadian population based on triglyceride thresholds to predict NAFLD risk. We proposed a Decision Tree based method to evaluate the risk of developing NAFLD and its progression in the Canadian population, using Electronic Medical Records (EMRs) by exploring novel risk factors for NAFLD. Our results show proposed method could potentially help physicians make more informed choices about their management of patients with NAFLD. Employing the proposed application in ordinary medical checkup is expected to lessen healthcare expenditures compared with administering additional complicated test.
机译:NAFLD的预防和诊断是医疗界不断关注的领域。非侵入性测试的准确性缺乏进行诊断和分期诊断的特异性和敏感性这一事实使筛查变得复杂。目前,尚无基于非侵入性ATP III标准的预测方法可用于诊断NAFLD风险。首先,这项研究的目的是开发一种基于机器学习的方法,以便使用2005年针对代谢综合征(MetS)更新的ATP III临床标准的危险因素来识别罹患NAFLD风险增加的个体。其次,要验证意大利肝病研究协会(IASF)定义的定量评分的相对能力,并根据甘油三酸酯阈值明确预测加拿大人群的NAFLD风险,明确为加拿大人群定义的指南。我们使用电子病历(EMR),通过探索NAFLD的新危险因素,提出了一种基于决策树的方法来评估在加拿大人群中发展NAFLD的风险及其进展。我们的结果表明,所提出的方法可以潜在地帮助医生对NAFLD患者的治疗做出更明智的选择。与进行额外的复杂测试相比,将拟议的应用程序应用于普通体检有望减少医疗保健支出。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号